my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Short description
Created in 1996 and recognised as being in the Public Interest, the Fondation Jérôme Lejeune works on the research of genetic intellectual disabilities: Trisomy 21 (Down Syndrome), "Cri du chat" syndrome, Fragile X Syndrome, monosomies... In order to find a treatment in the future to cure patients affected by intellectual deficiencies, the Fondation Jérôme Lejeune finances about 40 research programs all over the world each year. In France, it is the largest provider of funds for research on Trisomy 21 (Down Syndrome).
Watchlist
This is where you can add this association to your personal favourites
Additional Information
NovAliX to Collaborate with the Fondation Jérôme Lejeune on Down Syndrome (Trisomy 21)
NovAliX announced that it has entered into a multi-year drug research collaboration in the field of trisomy 21 with the Fondation Jérôme Lejeune.NovAliX will use its expertise and capabilities in medicinal chemistry and structural biology to develop small molecule lead candidates targeting ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
